pharmacodynamics
Showing 6651 - 6675 of 7,764
Rheumatoid Arthritis Trial in Worldwide (Adalimumab, current formulation, Adalimumab, new formulation)
Completed
- Rheumatoid Arthritis
- Adalimumab, current formulation
- Adalimumab, new formulation
-
Mesa, Arizona
- +20 more
Jun 10, 2014
Healthy Volunteers, Bacterial Infections Trial in Adelaide (RPX7009, Biapenem, Normal saline)
Completed
- Healthy Volunteers
- Bacterial Infections
- RPX7009
- +2 more
-
Adelaide, South Australia, AustraliaCMAX
Jul 9, 2013
Pharmacokinetics and Pharmacodynamics Trial in Seoul (Alogliptin)
Completed
- Pharmacokinetics and Pharmacodynamics
-
Seoul, Korea, Republic of(unnamed)
Feb 17, 2013
Type 1 Diabetes Trial in Graz (Insulin LISPRO)
Completed
- Type 1 Diabetes
- Insulin LISPRO
-
Graz, Styria, AustriaMedical University of Graz
Feb 25, 2014
Hepatitis B, HBV Trial in Worldwide (Single Ascending Dose (SAD) Cohorts GS-9620, Multiple Ascending Dose (MAD) Cohorts)
Completed
- Hepatitis B
- HBV
- Single Ascending Dose (SAD) Cohorts GS-9620
- Multiple Ascending Dose (MAD) Cohorts
-
Phoenix, Arizona
- +22 more
Nov 13, 2013
Severe Sepsis Trial in United States (AZD9773 (CytoFab), Placebo)
Completed
- Severe Sepsis
- AZD9773 (CytoFab)
- Placebo
-
Birmingham, Alabama
- +25 more
Jul 19, 2013
Intradermal Injections Trial (MicronJet)
Completed
- Intradermal Injections
- MicronJet
- (no location specified)
May 8, 2013
Hypercholesterolemia Trial in Seoul (Rosuvastatin)
Completed
- Hypercholesterolemia
-
Seoul, Korea, Republic ofClinical Trials Center, Seoul National University Hospital
May 15, 2014
Spasticity Due to Cerebral Palsy Trial in Louisville (Zanaflex Capsules)
Terminated
- Spasticity Due to Cerebral Palsy
- Zanaflex Capsules
-
Louisville, KentuckyUniversity of Louisville Department of Neurology dba Kentucky Ne
Jun 10, 2013
Healthy Trial in New Haven (PF-06291874, )
Completed
- Healthy
- PF-06291874
- placebo
-
New Haven, ConnecticutPfizer Investigational Site
Apr 1, 2013
Neuromuscular Blockade, Anesthesia Trial in Munich (Single-Shot Propofol, 30min infusion Propofol, Remifentanil infusion)
Completed
- Neuromuscular Blockade
- Anesthesia
- Single-Shot Propofol
- +8 more
-
Munich, Bavaria, GermanyKlinik für Anaesthesiologie, Klinikum rechts der Isar der Techni
May 7, 2014
Depression Trial in Taito-Ku (BMS-820836, Placebo matching BMS-820836)
Completed
- Depression
- BMS-820836
- Placebo matching BMS-820836
-
Taito-Ku, Tokyo, JapanLocal Institution
Jun 7, 2013
Compensated Heart Failure Trial in Barcelona (torasemide-PR, Furosemide-IR, torasemide-IR)
Terminated
- Compensated Heart Failure
- torasemide-PR
- +2 more
-
Barcelona, SpainCentre d'Investigació de Medicaments (CIM), Hospital de la Santa
Apr 24, 2013
Prostate Tumors Trial in San Francisco, Boston, Houston (Abiraterone acetate, prednisone/prednisolone or dexamethasone)
Completed
- Prostate Neoplasms
- Abiraterone acetate
- prednisone/prednisolone or dexamethasone
-
San Francisco, California
- +2 more
Mar 27, 2014
Pulmonary Disease, Chronic Obstructive Trial (99mTc-radiolabelled tiotropium, non-radiolabelled tiotropium)
Completed
- Pulmonary Disease, Chronic Obstructive
- 99mTc-radiolabelled tiotropium
- non-radiolabelled tiotropium
- (no location specified)
Jun 20, 2014
Breast Cancer, Colorectal Cancer, Lung Cancer Trial run by the NCCIH (mistletoe extract, gemcitabine HCl)
Terminated
- Breast Cancer
- +3 more
- mistletoe extract
- gemcitabine hydrochloride
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Jun 17, 2013
Stage IV Prostate Cancer, Bone Metastases, Adenocarcinoma of the Prostate Trial run by the NCI (alendronate sodium,
Terminated
- Stage IV Prostate Cancer
- +3 more
- alendronate sodium
- ketoconazole
-
Bethesda, MarylandMedicine Branch
Apr 21, 2014
Multiple Sclerosis (MS) Trial in London (Interferon beta 1a, (IM) AVONEX®)
Completed
- Multiple Sclerosis (MS)
- Interferon beta 1a
- (IM) AVONEX®
-
London, United KingdomHammersmith Medicines Research
May 22, 2013
Healthy Trial in Neuss (BI 135585 XX)
Completed
- Healthy
- BI 135585 XX
-
Neuss, Germany1283.34.1 Boehringer Ingelheim Investigational Site
Mar 6, 2013